FDA Issues Updated Compliance Program For Infant Formula
Portfolio Pulse from Benzinga Newsdesk
The FDA has issued an updated compliance program for infant formula, which may affect companies such as Abbott Laboratories (ABT) and Perrigo Company (PRGO).
October 06, 2023 | 7:58 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The FDA's updated compliance program for infant formula may affect Abbott Laboratories.
As a producer of infant formula, Abbott Laboratories could be affected by the FDA's updated compliance program. This could potentially lead to increased costs or changes in production processes, which could negatively impact the company's stock price in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
The FDA's updated compliance program for infant formula may affect Perrigo Company.
As a producer of infant formula, Perrigo Company could be affected by the FDA's updated compliance program. This could potentially lead to increased costs or changes in production processes, which could negatively impact the company's stock price in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80